Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Life in the Age of AI: an elderly couple traveled 300 km across Malaysia to see a building that doesn’t exist

Humans are not critical of AI advice and creations, despite the high probability of «hallucinations» as well as deliberate hoaxes. These two people watched a misleading video and went on a trip.

Meta is trying to win the AI race. A new partnership with AWS could help

For Silicon Valley giants, getting ahead in the artificial intelligence race requires more than building the biggest, most capable models; they’re also competing to get third-party developers to build new applications based on their technology.

Now, Meta is teaming up with Amazon’s cloud computing unit, Amazon Web Services, on an initiative designed to do just that.

The program will provide six months of technical support from both companies’ engineers and $200,000 in AWS cloud computing credits each to 30 US startups looking to build AI tools on Meta’s Llama AI model. The partnership is set to be unveiled at AWS Summit in New York City on Wednesday.

Six-hour ‘undo’ button: GAI-17 rewinds stroke damage and may beat Alzheimer’s

Stroke kills millions, but Osaka researchers have unveiled GAI-17, a drug that halts toxic GAPDH clumping, slashes brain damage and paralysis in mice—even when given six hours post-stroke—and shows no major side effects, hinting at a single therapy that could also tackle Alzheimer’s and other tough neurological disorders.

AI slows down open source developers. Peter Naur can teach us why

Metr recently published a paper about the impact AI tools have on open-source developer productivity1. They show that when open source developers working in codebases that they are deeply familiar with use AI tools to complete a task, then they take longer to complete that task compared to other tasks where they are barred from using AI tools. Interestingly the developers predict that AI will make them faster, and continue to believe that it did make them faster, even after completing the task slower than they otherwise would!

Steroid Hormone Vitamin D: Implications for Cardiovascular Disease

Understanding of vitamin D physiology is important because about half of the population is being diagnosed with deficiency and treated with supplements. Clinical guidelines were developed based on observational studies showing an association between low serum levels and increased cardiovascular risk. However, new randomized controlled trials have failed to confirm any cardiovascular benefit from supplementation in the general population. A major concern is that excess vitamin D is known to cause calcific vasculopathy and valvulopathy in animal models. For decades, administration of vitamin D has been used in rodents as a reliable experimental model of vascular calcification. Technically, vitamin D is a misnomer. It is not a true vitamin because it can be synthesized endogenously through ultraviolet exposure of the skin. It is a steroid hormone that comes in 3 forms that are sequential metabolites produced by hydroxylases. As a fat-soluble hormone, the vitamin D-hormone metabolites must have special mechanisms for delivery in the aqueous bloodstream. Importantly, endogenously synthesized forms are carried by a binding protein, whereas dietary forms are carried within lipoprotein particles. This may result in distinct biodistributions for sunlight-derived versus supplement-derived vitamin D hormones. Because the cardiovascular effects of vitamin D hormones are not straightforward, both toxic and beneficial effects may result from current recommendations.